DK3515406T3 - Intrakamerale depoter til lægemiddeladministration - Google Patents
Intrakamerale depoter til lægemiddeladministration Download PDFInfo
- Publication number
- DK3515406T3 DK3515406T3 DK17780606.4T DK17780606T DK3515406T3 DK 3515406 T3 DK3515406 T3 DK 3515406T3 DK 17780606 T DK17780606 T DK 17780606T DK 3515406 T3 DK3515406 T3 DK 3515406T3
- Authority
- DK
- Denmark
- Prior art keywords
- intracameral
- depots
- drug administration
- administration
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Nanotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662398985P | 2016-09-23 | 2016-09-23 | |
| PCT/US2017/053271 WO2018058048A1 (en) | 2016-09-23 | 2017-09-25 | Intracameral drug delivery depots |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3515406T3 true DK3515406T3 (da) | 2024-10-14 |
Family
ID=60022215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17780606.4T DK3515406T3 (da) | 2016-09-23 | 2017-09-25 | Intrakamerale depoter til lægemiddeladministration |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US12171869B2 (enExample) |
| EP (2) | EP3515406B1 (enExample) |
| JP (2) | JP7430529B2 (enExample) |
| KR (3) | KR102814241B1 (enExample) |
| CN (1) | CN109982683A (enExample) |
| AU (1) | AU2017331444B2 (enExample) |
| DK (1) | DK3515406T3 (enExample) |
| ES (1) | ES2989941T3 (enExample) |
| IL (1) | IL265421B2 (enExample) |
| WO (1) | WO2018058048A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017062770A1 (en) | 2015-10-08 | 2017-04-13 | Silverberg Noah | Punctal plug and bioadhesives |
| KR102814241B1 (ko) * | 2016-09-23 | 2025-05-29 | 인셉트, 엘엘씨 | 전안방내 약물 전달 데포 |
| WO2018067882A1 (en) | 2016-10-05 | 2018-04-12 | Titan Pharmaceuticals, Inc. | Implantable devices for drug delivery with reduced burst release |
| CA3133172A1 (en) * | 2019-03-13 | 2020-09-17 | Susmita Bose | Enzyme-degradable hydrogel for delivery of a payload |
| WO2020219892A1 (en) * | 2019-04-25 | 2020-10-29 | Ocular Therapeutix, Inc. | Hydrogel implants for lowering intraocular pressure |
| US20200337989A1 (en) * | 2019-04-25 | 2020-10-29 | Ocular Therapeutix, Inc. | Ocular hydrogel tyrosine kinase inhibitor implants |
| AU2020262932B2 (en) * | 2019-04-25 | 2025-11-13 | Ocular Therapeutix, Inc. | Intracanalicular hydrogel inserts for the delivery of anesthetics |
| CN115066232B (zh) * | 2020-02-06 | 2024-12-10 | 视尔普斯眼科公司 | 用于治疗眼病的组合物和方法 |
| CA3171563A1 (en) * | 2020-03-25 | 2021-09-30 | Charles D. Blizzard | Ocular implant containing a tyrosine kinase inhibitor |
| EP4142664A4 (en) | 2020-04-27 | 2024-05-29 | Ocular Therapeutix, Inc. | METHODS FOR TREATING ALLERGIC CONJUNCTIVITIS |
| CN116133664A (zh) * | 2020-07-16 | 2023-05-16 | 视觉治疗股份有限公司 | 含有糖皮质激素的眼部插入物 |
| EP3973952B1 (en) | 2020-09-24 | 2024-02-14 | Ocular Therapeutix, Inc. | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine |
| EP4216929A1 (en) | 2020-09-24 | 2023-08-02 | Ocular Therapeutix, Inc. | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent |
| WO2022251710A2 (en) * | 2021-05-28 | 2022-12-01 | Sight Sciences, Inc. | Intraocular devices, systems, and methods |
| CN114748436B (zh) * | 2022-05-30 | 2023-05-16 | 迪沙药业集团有限公司 | 一种硝苯地平组合物及其制备方法 |
| CA3264199A1 (en) * | 2022-08-12 | 2024-02-15 | Ocular Therapeutix, Inc. | ORGANOGELS FOR PROLONGED MEDICINE ADMINISTRATION, THEIR PREPARATION PROCESSES AND USE |
| CN115337453A (zh) * | 2022-08-15 | 2022-11-15 | 珠海肤原生物科技有限公司 | 一种载有2-氧杂环庚烷酮的均聚物微球的医用无菌胶原蛋白产品的制备 |
| WO2024191453A1 (en) * | 2023-03-10 | 2024-09-19 | Clearstream Technologies Limited | Radiation spacer hydrogels, methods of forming, and methods of use |
| JP2026520094A (ja) | 2023-04-11 | 2026-06-22 | オキュラ セラピューティクス，インコーポレイテッド | アキシチニブ多形ｉｖを含む眼科インプラント |
| TW202547517A (zh) * | 2024-06-06 | 2025-12-16 | 美商視爾普斯眼科公司 | 用於治療眼部疾病之組合物及方法 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3640741A (en) | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
| US3865108A (en) | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
| US4002173A (en) | 1974-07-23 | 1977-01-11 | International Paper Company | Diester crosslinked polyglucan hydrogels and reticulated sponges thereof |
| DE2437629C3 (de) | 1974-08-05 | 1978-09-21 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von unlöslichen in Wasser nur wenig quellbaren Polymerisaten von N-Vinyllactamen |
| US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
| US4207893A (en) | 1977-08-29 | 1980-06-17 | Alza Corporation | Device using hydrophilic polymer for delivering drug to biological environment |
| US5160745A (en) | 1986-05-16 | 1992-11-03 | The University Of Kentucky Research Foundation | Biodegradable microspheres as a carrier for macromolecules |
| US4741872A (en) | 1986-05-16 | 1988-05-03 | The University Of Kentucky Research Foundation | Preparation of biodegradable microspheres useful as carriers for macromolecules |
| IL82834A (en) | 1987-06-09 | 1990-11-05 | Yissum Res Dev Co | Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5304595A (en) | 1988-11-21 | 1994-04-19 | Collagen Corporation | Collagen-polymer conjugates |
| US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| IL90193A (en) | 1989-05-04 | 1993-02-21 | Biomedical Polymers Int | Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
| FR2657018A1 (fr) | 1990-01-12 | 1991-07-19 | Merck Sharp & Dohme | Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation. |
| US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| US6177401B1 (en) | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| US6371975B2 (en) | 1998-11-06 | 2002-04-16 | Neomend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
| IL135800A0 (en) | 1997-10-27 | 2001-05-20 | Univ California | Methods and pharmaceutical compositions for the closure of retinal breaks |
| US6632457B1 (en) | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
| US6958212B1 (en) | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| TWI262914B (en) | 1999-07-02 | 2006-10-01 | Agouron Pharma | Compounds and pharmaceutical compositions for inhibiting protein kinases |
| US7141581B2 (en) | 1999-07-02 | 2006-11-28 | Agouron Pharmaceuticals, Inc. | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| US20050049578A1 (en) | 2000-04-14 | 2005-03-03 | Hosheng Tu | Implantable ocular pump to reduce intraocular pressure |
| US6699493B2 (en) | 2000-11-29 | 2004-03-02 | Oculex Pharmaceuticals, Inc. | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| CA2438193A1 (en) | 2001-02-26 | 2002-09-06 | Duke University | Novel dendritic polymers and their biomedical uses |
| US6913765B2 (en) | 2001-03-21 | 2005-07-05 | Scimed Life Systems, Inc. | Controlling resorption of bioresorbable medical implant material |
| US20040131582A1 (en) | 2002-02-26 | 2004-07-08 | Grinstaff Mark W. | Novel dendritic polymers and their biomedical uses |
| US20040024345A1 (en) | 2002-04-19 | 2004-02-05 | Morteza Gharib | Glaucoma implant with valveless flow bias |
| US7351430B2 (en) | 2002-11-06 | 2008-04-01 | Uluru Inc. | Shape-retentive hydrogel particle aggregates and their uses |
| US20040137059A1 (en) | 2003-01-09 | 2004-07-15 | Thierry Nivaggioli | Biodegradable ocular implant |
| US7129210B2 (en) | 2003-07-23 | 2006-10-31 | Covalent Medical, Inc. | Tissue adhesive sealant |
| US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
| US20050244458A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
| WO2006031358A2 (en) | 2004-08-13 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses |
| WO2006031388A2 (en) | 2004-08-20 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dentritic polymers, crosslinked gels, and their uses in orthopedic applications |
| US20080038316A1 (en) | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
| WO2007001926A2 (en) | 2005-06-24 | 2007-01-04 | Hyperbranch Medical Technology, Inc. | Low-swelling hydrogel sealants for wound repair |
| WO2007005249A2 (en) | 2005-06-29 | 2007-01-11 | Hyperbranch Medical Technology, Inc. | Nanoparticles and dendritic-polymer-based hydrogels comprising them |
| US9173773B2 (en) * | 2006-06-21 | 2015-11-03 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
| US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
| JP5890182B2 (ja) * | 2009-02-12 | 2016-03-22 | インセプト エルエルシー | ヒドロゲルプラグによる薬物送達 |
| US20100247606A1 (en) * | 2009-03-25 | 2010-09-30 | Allergan, Inc. | Intraocular sustained release drug delivery systems and methods for treating ocular conditions |
| US8895508B2 (en) | 2009-07-24 | 2014-11-25 | Yasuhiki Tabata | Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particles |
| US7856528B1 (en) | 2009-08-11 | 2010-12-21 | Texas Memory Systems, Inc. | Method and apparatus for protecting data using variable size page stripes in a FLASH-based storage system |
| EP3960215B1 (en) | 2009-12-15 | 2024-10-16 | Incept, LLC | Implants and biodegradable fiducial markers |
| KR102337046B1 (ko) | 2010-01-22 | 2021-12-08 | 알러간, 인코포레이티드 | 전방내 서방성 치료제 이식물 |
| US8889193B2 (en) | 2010-02-25 | 2014-11-18 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
| EP2555749B1 (en) | 2010-04-06 | 2016-10-26 | Allergan, Inc. | Sustained-release reservoir implants for intracameral drug delivery |
| US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
| US10226417B2 (en) * | 2011-09-16 | 2019-03-12 | Peter Jarrett | Drug delivery systems and applications |
| US9205150B2 (en) | 2011-12-05 | 2015-12-08 | Incept, Llc | Medical organogel processes and compositions |
| WO2014120866A1 (en) | 2013-01-31 | 2014-08-07 | Icon Bioscience, Inc. | Sustained release formulations for the treatment of intraocular pressure or glaucoma |
| EP2964194B1 (en) * | 2013-03-05 | 2022-08-17 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery |
| ES2751681T3 (es) | 2013-03-15 | 2020-04-01 | Allergan Inc | Implante intraocular que contiene prostamida |
| WO2014165308A2 (en) | 2013-04-01 | 2014-10-09 | Allergan, Inc. | Microsphere drug delivery system for sustained intraocular release |
| US20160296627A1 (en) | 2013-12-06 | 2016-10-13 | Envisia Therapeutics Inc. | Intracameral implant for treatment of an ocular condition |
| AU2015360469B2 (en) * | 2014-12-10 | 2021-03-25 | Incept, Llc | Hydrogel drug delivery implants |
| AU2016361579B2 (en) | 2015-11-25 | 2022-08-04 | Incept, Llc | Shape changing drug delivery devices and methods |
| KR102814241B1 (ko) | 2016-09-23 | 2025-05-29 | 인셉트, 엘엘씨 | 전안방내 약물 전달 데포 |
-
2017
- 2017-09-25 KR KR1020247011510A patent/KR102814241B1/ko active Active
- 2017-09-25 AU AU2017331444A patent/AU2017331444B2/en active Active
- 2017-09-25 WO PCT/US2017/053271 patent/WO2018058048A1/en not_active Ceased
- 2017-09-25 US US15/714,633 patent/US12171869B2/en active Active
- 2017-09-25 KR KR1020237011914A patent/KR20230053707A/ko not_active Ceased
- 2017-09-25 JP JP2019515849A patent/JP7430529B2/ja active Active
- 2017-09-25 KR KR1020197011614A patent/KR102520771B1/ko active Active
- 2017-09-25 CN CN201780072266.9A patent/CN109982683A/zh active Pending
- 2017-09-25 EP EP17780606.4A patent/EP3515406B1/en active Active
- 2017-09-25 IL IL265421A patent/IL265421B2/en unknown
- 2017-09-25 EP EP23154758.9A patent/EP4197527B1/en active Active
- 2017-09-25 ES ES17780606T patent/ES2989941T3/es active Active
- 2017-09-25 DK DK17780606.4T patent/DK3515406T3/da active
-
2022
- 2022-04-08 JP JP2022064398A patent/JP7486539B2/ja active Active
- 2022-08-18 US US17/890,997 patent/US20220401356A1/en not_active Abandoned
-
2024
- 2024-11-11 US US18/943,498 patent/US20250144012A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017331444A1 (en) | 2019-04-18 |
| KR102520771B1 (ko) | 2023-04-12 |
| JP2019529455A (ja) | 2019-10-17 |
| ES2989941T3 (es) | 2024-11-28 |
| CA3038075A1 (en) | 2018-03-29 |
| US20250144012A1 (en) | 2025-05-08 |
| KR20230053707A (ko) | 2023-04-21 |
| KR102814241B1 (ko) | 2025-05-29 |
| JP7486539B2 (ja) | 2024-05-17 |
| WO2018058048A1 (en) | 2018-03-29 |
| IL265421B2 (en) | 2024-04-01 |
| BR112019005594A2 (pt) | 2019-08-13 |
| JP2022091998A (ja) | 2022-06-21 |
| US12171869B2 (en) | 2024-12-24 |
| EP4197527A1 (en) | 2023-06-21 |
| EP4197527B1 (en) | 2026-08-05 |
| EP3515406B1 (en) | 2024-07-24 |
| CN109982683A (zh) | 2019-07-05 |
| KR20240051303A (ko) | 2024-04-19 |
| US20180085307A1 (en) | 2018-03-29 |
| IL265421B1 (en) | 2023-12-01 |
| AU2017331444B2 (en) | 2023-08-17 |
| EP3515406A1 (en) | 2019-07-31 |
| IL265421A (en) | 2019-05-30 |
| JP7430529B2 (ja) | 2024-02-13 |
| US20220401356A1 (en) | 2022-12-22 |
| KR20190057353A (ko) | 2019-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3493862T3 (da) | Lægemiddelindgivelsesanordning | |
| IL265421A (en) | Means for transferring medicine to the anterior chamber in the eye | |
| DK3703785T3 (da) | Lægemiddelindgivelsesanordning | |
| DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
| DK3368108T3 (da) | Medikamenttilførselsanordning | |
| DK3302638T3 (da) | Anordning til indgivelse af lægemidler | |
| EP3302634C0 (en) | DRUG ADMINISTRATION DEVICE | |
| DK3099356T3 (da) | Medikamentadministrationsanordning | |
| DK3519018T3 (da) | Medikamentadministrationsanordning | |
| DK3204876T3 (da) | Lægemiddelafgivelsesindretning | |
| DK3220976T3 (da) | Medikamenttilførselsanordning | |
| DK3171921T3 (da) | Lægemiddelafgivelsesindretning | |
| DK3496783T3 (da) | Medikamentadministrationsanordning | |
| DK3380139T3 (da) | Medikamentadministrationsanordning | |
| DK3400045T3 (da) | Medikamentadministrationsanordning | |
| EP3380134C0 (en) | MEDICATION INJECTION DEVICE | |
| DK3380146T3 (da) | Medikamentadministrationsanordning | |
| DK3558438T3 (da) | Lægemiddelindgivelsesanordning | |
| DK3236935T3 (da) | Farmaceutisk doseringsform til anvendelse på slimhinder | |
| PL3655038T3 (pl) | Kompozycja farmaceutyczna | |
| EP3213736C0 (en) | DRUG DELIVERY DEVICE | |
| DK3558423T3 (da) | Medikamentadministrationsanordning | |
| DK3570911T3 (da) | Medikamenttilførselsanordning | |
| EP3380143C0 (en) | DRUG INJECTION DEVICE | |
| EP3244868C0 (en) | DRUG DELIVERY DEVICES |